Search Results

240 results for fsa

Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns

By Rich Duprey, InvestorPlace Contributor

We’re heading into our third year of this raging bull market, and there doesn’t appear to be any end in sight for these high-return stocks.

Zsa Zsa Gabor Dead at 99: 9 Things to Remember About the Actress

By Karl Utermohlen, InvestorPlace Writer

Hunarian actress Zsa Zsa Gabor has died at age 99. Here are nine things you should know about one of the most glamorous celebrities Hollywood…

Amarin’s Vascepa Approval Seems Fishy for Patients and AMRN Investors

By Dana Blankenhorn, InvestorPlace Contributor

What does the FDA’s recent approval of Vascepa mean for Amarin stock? Is the company really a target for buyout offers?

3 Stocks to Watch on Monday: Acadia Pharmaceuticals Inc. (ACAD), Caterpillar Inc. (CAT) and Tesla Motors Inc (TSLA)

By Karl Utermohlen, InvestorPlace Writer

Acadia Pharmaceuticals (ACAD) gets an FDA green light for Nuplazid, Caterpillar (CAT) is closing a number of plants over lowered demand and Tesla Motors (TSLA)…

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com

What will the stock market do today? All eyes are on Jerome Powell ahead of his afternoon Federal Reserve comments. Here’s what to know.

Advantage the Drift in Senseonics Stock Before It Recovers on FDA Nod

By Mark R. Hake, CFA

Take advantage of the drift in Senseonics before it recovers with a nod by the FDA nod. SENS stock will skyrocket after FDA approval.

Potash Corporation of Saskatchewan (USA) (POT) and Agrium Inc. (USA) (AGU) Make It Official

By John Kilhefner, Senior Managing Editor, Lango Franchise

Potash (POT) and Agrium (AGU) are the latest in the agricultural market to combine forces and make a bet on rebounding commodity prices.

FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock

By Larry Ramer, InvestorPlace Contributor

The FDA’s recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen’s aspirations. OCGN stock remains…

7 Stocks to Sell Before They Implode

By Will Ashworth, InvestorPlace Contributor

These seven stocks to sell — including two of 2016’s hottest names — are too risky to hold as we enter the ninth year of…

NVAX Stock Price Predictions: Where Will Novavax Go From Here?

By Eddie Pan, InvestorPlace Financial News Writer

NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA’s advisory panel yesterday.

3 Stocks to Watch on Wednesday: Moneygram International Inc (MGI), Trevena Inc (TRVN) and Tetraphase Pharmaceuticals Inc (TTPH)

By Karl Utermohlen, InvestorPlace Writer

Moneygram (MGI) acquisition rejected, FDA accepts Trevena (TRVN) drug application and Tetraphase Pharmaceuticals (TTPH) submitted drug to FDA.

FST Stock: Golden Nugget, Landry’s to Go Public via Fertitta Entertainment SPAC Merger

By William White, InvestorPlace Writer

Golden Nugget/Landry’s is going public via a SPAC merger with Fast Acquisition (FST) and FST stock was up on the news Monday.

Orphazyme Stock Is a Dead-End for Investors After FDA Rejection

By Muslim Farooque, InvestorPlace Contributor

ORPH stock has a virtually impossible task ahead of it in picking itself after FDA’s rejection of the Danish biopharma’s Arimoclomol drug.

KMPH Stock: The Big News That Has KemPharm Soaring Today

By Robert Lakin, InvestorPlace Contributor

KemPharm’s prodrug development platform got a huge boost from the FDA’s new drug application nod for an ADHD treatment.

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants

By Hope Mutie, InvestorPlace Contributor

After the FDA’s authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.

Why Barrick Gold Corporation (USA) (ABX), Seagate Technology PLC (STX) and Vale SA (VALE) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Barrick Gold Corporation (ABX), Seagate Technology (STX) and Vale (VALE) couldn’t win for losing on Thursday. Here’s what investors need to know.

Why Encana Corporation (USA) (ECA), On Deck Capital Inc (ONDK) and Vale SA (ADR) (VALE) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Encana (ECA), On Deck Capital (ONDK) and Vale (VALE) never even had a prayer of making gains on Tuesday.

Fisker News Alert: Why FSR Stock Is Surging Thursday

By William White, InvestorPlace Writer

Fisker (FSR) news for Thursday concerning the future of its manufacturing for its Ocean EV have FSR stock taking off on Thursday.

No, The New FDA Dietary Guidelines Don’t Spell Doom for KO and PEP

By James Brumley, InvestorPlace Feature Writer

KO and PEP were deemed most vulnerable to the FDA’s latest caloric intake suggestion, but it’s a standard with more bark than bite.

MSA Stock Earnings: MSA Safety Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

MSA stock results show that MSA Safety beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

MSA Stock Earnings: MSA Safety Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings

MSA stock results show that MSA Safety beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

The Next Real Estate Bubble: Rentals

By Ethan Roberts, InvestorPlace Contributor

We could be in the early stages of a “landlord” bubble — fueled by investors scrambling to pick up cheap rental homes for long-term cash…

Health Care Companies Slow On the Social-Media Draw

By Barry Cohen, Health Care Writer

Businesses are too worried about FDA pushback.

TSLA Stock: What Really Matters About the Full Self-Driving Rollout

By Wayne Duggan, InvestorPlace Contributor

Viral online videos demonstrate how bad Tesla’s FSD software is. If FSD tarnishes Tesla’s reputation, it could be bad news for TSLA stock.

4 – 10 of 240 results